Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Mustafa Çoban, Uğur Bilge, Hale Balseven, Hilmi Uysal & Betül Artut. (2023) The economic evaluation of ALS care: quality and cost. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 502-513.
Read now
Read now
James D. Berry, Marie Blanchard, Kerina Bonar, Emma Drane, Molly Murton, Uffe Ploug, Kristen Ricchetti-Masterson, Natasa Savic, Emma Worthington & Terry Heiman-Patterson. (2023) Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 436-448.
Read now
Read now
Rubika Balendra, Ashley R. Jones, Ahmad Al Khleifat, Theresa Chiwera, Paul Wicks, Carolyn A. Young, Pamela J. Shaw, Martin R. Turner, P. Nigel Leigh & Ammar Al-Chalabi. (2023) Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 71-81.
Read now
Read now
Vittorio Emanuele Bianchi, Pomares Fredy Herrera & Rizzi Laura. (2021) Effect of nutrition on neurodegenerative diseases. A systematic review. Nutritional Neuroscience 24:10, pages 810-834.
Read now
Read now
Andrea Barp, Francesca Gerardi, Andrea Lizio, Valeria Ada Sansone & Christian Lunetta. (2020) Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials. Expert Opinion on Emerging Drugs 25:2, pages 145-164.
Read now
Read now
Alison Gowland, Sarah Opie-Martin, Kirsten M. Scott, Ashley R. Jones, Puja R. Mehta, Christine J. Batts, Cathy M. Ellis, P. Nigel Leigh, Christopher E. Shaw, Jemeen Sreedharan & Ammar Al-Chalabi. (2019) Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020–2116. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 264-274.
Read now
Read now
Rubika Balendra, Ahmad Al Khleifat, Ton Fang & Ammar Al-Chalabi. (2019) A standard operating procedure for King’s ALS clinical staging. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 159-164.
Read now
Read now
Priya Treesa Thomas, Manjusha G. Warrier, Arun Sadasivan, Bhuvaneshwari Balasubramanium, Veeramani Preethish-kumar, Saraswati Nashi, Kiran Polavarapu, Gopalkrishna Krishna, Seena Vengalil, Prakashi Rajaram & Atchayaram Nalini. (2018) Caregiver burden and quality of life of patients with amyotrophic lateral sclerosis in India. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 606-610.
Read now
Read now
Giuseppe Fiorentino & Antonio M. Esquinas. (2018) Cost-effectiveness associated with amyotrophic lateral sclerosis: some questions and answers pending. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 315-316.
Read now
Read now
Juyeon Oh & Jung A. Kim. (2018) Factor analysis of the Zarit Burden Interview in family caregivers of patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 50-56.
Read now
Read now
Lisa Meng, Amy Bian, Scott Jordan, Andrew Wolff, Jeremy M. Shefner & Jinsy Andrews. (2018) Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 134-142.
Read now
Read now
Anne Hogden, Geraldine Foley, Robert D Henderson, Natalie James & Samar M Aoun. (2017) Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare 10, pages 205-215.
Read now
Read now
Ton Fang, Ahmad Al Khleifat, Daniel R Stahl, Claudia Lazo La Torre, Caroline Murphy, Carolyn Young, Pamela J Shaw, P Nigel Leigh & Ammar Al-Chalabi. (2017) Comparison of the King’s and MiToS staging systems for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 227-232.
Read now
Read now
Juyeon Oh, Gwi-Ryung Son Hong, Seung Hyun Kim & Jung A Kim. (2017) Translation and Psychometric Evaluation of a Korean Version of the Amyotrophic Lateral Sclerosis-Specific Quality of Life – Revised. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:1-2, pages 92-98.
Read now
Read now
Articles from other publishers (25)
Kun Yang, Hongxia Xue, Li Li & Shan Tang. (2023) Caregivers of ALS Patients: Their Experiences and Needs. Neuroethics 17:1.
Crossref
Crossref
Katie Stenson, Lasair O'Callaghan, Jennifer Mellor, Jack Wright, Gregor Gibson, Lucy Earl, Sophie Barlow & Christina Nicole Fournier. (2023) Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey. Journal of the Neurological Sciences 452, pages 120764.
Crossref
Crossref
Heather M. Young, Tina R. Kilaberia, Robin Whitney, Benjamin M. Link, Janice F. Bell, Orly Tonkikh, Jessica Famula & Björn Oskarsson. (2023)
Needs of persons living with
ALS
at home and their family caregivers: A scoping review
. Muscle & Nerve 68:3, pages 240-249.
Crossref
Crossref
Mario B. PradoJrJr, Geohanna Hamoy-Jimenez & Karen Joy Adiao. (2023) Characteristic and management motor neuron disease in the largest tertiary hospital in the Philippines: A one-year period cross sectional analytic study. Journal of Clinical Neuroscience 112, pages 68-72.
Crossref
Crossref
Mona Ahmed, Mayca Marín, Daniella How, Elda Judica, Peppino Tropea, Ellen Bentlage, Joaquim J Ferreira, Raquel Bouça-Machado & Michael Brach. (2022) End Users’ and Other Stakeholders’ Needs and Requirements in the Development of a Personalized Integrated Care Platform (PROCare4Life) for Older People With Dementia or Parkinson Disease: Mixed Methods Study. JMIR Formative Research 6:11, pages e39199.
Crossref
Crossref
Juyeon Oh, SeolHwa Moon & Kyongok Park. (2022) Amyotrophic lateral sclerosis in social media: Content analysis of YouTube videos. Health Informatics Journal 28:2, pages 146045822211059.
Crossref
Crossref
Lidia García-Pérez, Renata Linertová, Cristina Valcárcel-Nazco, Manuel Posada, Inigo Gorostiza & Pedro Serrano-Aguilar. (2021) Cost-of-illness studies in rare diseases: a scoping review. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
K. Achtert & L. Kerkemeyer. (2021) The economic burden of amyotrophic lateral sclerosis: a systematic review. The European Journal of Health Economics 22:8, pages 1151-1166.
Crossref
Crossref
Seo Yeon Yoon, Han-Kyoul Kim, Mi Ji Kim, Jee Hyun Suh & Ja-Ho Leigh. (2021) Factors associated with assisted ventilation use in amyotrophic lateral sclerosis: a nationwide population-based study in Korea. Scientific Reports 11:1.
Crossref
Crossref
Seong-il Oh, Jin-Sung Park, Jung-Joon Sung & Seung Hyun Kim. (2021) Clinical Scales Used in Motor Neuron Disease. Journal of the Korean Neurological Association 39:2 Suppl, pages 77-86.
Crossref
Crossref
Juyeon Oh, Jung-A Kim & Min Sun Chu. (2021) Family Caregiver Suffering in Caring for Patients with Amyotrophic Lateral Sclerosis in Korea. International Journal of Environmental Research and Public Health 18:9, pages 4937.
Crossref
Crossref
Fabiola De Marchi, Elena Contaldi, Luca Magistrelli, Roberto Cantello, Cristoforo Comi & Letizia Mazzini. (2021) Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians. Brain Sciences 11:2, pages 237.
Crossref
Crossref
Ammar Al-Chalabi, Adriano Chiò, Charlotte Merrill, Gerry Oster, Rebecca Bornheimer, Wendy Agnese & Stephen Apple. (2021) Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19. Journal of Neurology, Neurosurgery & Psychiatry 92:2, pages 165-171.
Crossref
Crossref
Erik Schönfelder, Alma Osmanovic, Lars Hendrik Müschen, Susanne Petri & Olivia Schreiber-Katz. (2020) Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Nimish J. Thakore, Erik P. Pioro, Belinda L. Udeh, Brittany R. Lapin & Irene L. Katzan. (2020) A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole. Value in Health 23:12, pages 1543-1551.
Crossref
Crossref
Vittorio Emanuele Bianchi, Laura Rizzi, Elena Bresciani, Robert J Omeljaniuk & Antonio Torsello. (2020) Androgen Therapy in Neurodegenerative Diseases. Journal of the Endocrine Society 4:11.
Crossref
Crossref
Gabriela M. Stegmann, Shira Hahn, Julie Liss, Jeremy Shefner, Seward Rutkove, Kerisa Shelton, Cayla Jessica Duncan & Visar Berisha. (2020) Early detection and tracking of bulbar changes in ALS via frequent and remote speech analysis. npj Digital Medicine 3:1.
Crossref
Crossref
Juyeon Oh, Seung Hyun Kim & Jung A Kim. (2019) Unmet supportive care needs mediate the relationship between functional status and quality of life in patients with amyotrophic lateral sclerosis. Palliative and Supportive Care 17:6, pages 650-654.
Crossref
Crossref
Alan Moore, Carolyn A. Young & Dyfrig A. Hughes. (2019) Health Utilities and Costs for Motor Neurone Disease. Value in Health 22:11, pages 1257-1265.
Crossref
Crossref
P. Corcia, S. Beltran, G. Lautrette, S. Bakkouche & P. Couratier. (2019) Staging amyotrophic lateral sclerosis: A new focus on progression. Revue Neurologique 175:5, pages 277-282.
Crossref
Crossref
Ton Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, Ashley Jones, P Nigel Leigh, Gilbert Bensimon & Ammar Al-Chalabi. (2018) Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. The Lancet Neurology 17:5, pages 416-422.
Crossref
Crossref
Jan Lewerenz, Gamze Ates, Axel Methner, Marcus Conrad & Pamela Maher. (2018) Oxytosis/Ferroptosis—(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System. Frontiers in Neuroscience 12.
Crossref
Crossref
Vittorio Bianchi, Vittorio Locatelli & Laura Rizzi. (2017) Neurotrophic and Neuroregenerative Effects of GH/IGF1. International Journal of Molecular Sciences 18:11, pages 2441.
Crossref
Crossref
Dan Geng, RuWei Ou, XiaoHui Miao, LiHong Zhao, QianQian Wei, XuePing Chen, Yan Liang, HuiFang Shang & Rong Yang. (2017) Patients’ self-perceived burden, caregivers’ burden and quality of life for amyotrophic lateral sclerosis patients: a cross-sectional study. Journal of Clinical Nursing 26:19-20, pages 3188-3199.
Crossref
Crossref
Alan Moore, Carolyn A. Young & Dyfrig A. Hughes. (2016) Economic Studies in Motor Neurone Disease: A Systematic Methodological Review. PharmacoEconomics 35:4, pages 397-413.
Crossref
Crossref